Can Cosentyx (secukinumab) cause cellulitis?
Cosentyx (secukinumab) can increase the risk of infections because it blocks IL-17A, a signal involved in immune defense. Infections are therefore a key safety concern for people taking it, and skin infections such as cellulitis can occur in this setting.[1][2]
That said, “cellulitis” is not listed as a specific common adverse effect in every safety summary. The practical takeaway is that any new or worsening skin infection symptoms after starting Cosentyx should be treated as potentially related until proven otherwise.[1]
What symptoms suggest cellulitis while on Cosentyx?
Cellulitis typically presents with rapidly developing skin redness and warmth that can spread over hours to days. People may also have:
- Pain or tenderness in the affected area
- Swelling
- Fever or chills
- Feeling unwell
Because you’re on an immunomodulating medicine, it’s important to contact a clinician promptly if symptoms start or worsen.
What should you do if you think it’s cellulitis?
Seek medical care urgently if you have signs consistent with cellulitis, especially if you also have fever, rapidly spreading redness, severe pain, or red streaking. Clinicians may need to:
- Confirm the diagnosis (and rule out abscess or other causes)
- Start antibiotics if appropriate
- Decide whether to pause Cosentyx during the infection episode
The safest approach is not to wait at home if symptoms are progressing.
Is this just “skin infection” risk, or does Cosentyx make it worse?
Cosentyx increases susceptibility to infections generally because it affects immune signaling involved in defense against certain pathogens.[1][2] If cellulitis occurs, it can progress faster or become more serious in some patients simply because the immune response is altered. This is one reason clinicians take infection symptoms seriously and may adjust treatment while treating the infection.
How soon after starting Cosentyx could cellulitis happen?
Cellulitis can happen any time during treatment, not only right after the first dose, because the increased infection risk persists while the medication is active. If the timing is close to a dose change or a flare in skin disease, it still needs prompt evaluation.
When is it more concerning (higher-risk situations)?
Doctors are more concerned when infection signs are severe or when there are risk factors such as:
- Diabetes or poor circulation
- Chronic skin conditions with breaks in the skin
- Prior recurrent cellulitis
- Immunosuppressing medications used alongside Cosentyx
If any of these apply, early treatment matters even more.
Could something else be mistaken for cellulitis in Cosentyx patients?
Yes. Skin inflammation from underlying conditions, allergic reactions, shingles, abscess, or other rashes can be confused with cellulitis. A clinician may need to examine the skin and sometimes do tests if the presentation is atypical or not improving with antibiotics.
What questions to ask your clinician
If you suspect cellulitis while on Cosentyx, useful questions include:
- Should I stop Cosentyx temporarily while I’m being treated for infection?
- What antibiotic is appropriate, and do I need dosing adjustments?
- How will we monitor for improvement or complications?
- When can I restart Cosentyx after the infection resolves?
---
Sources
[1] https://www.cosentyx.com/safety-information
[2] https://www.ema.europa.eu/en/medicines/human/EPAR/cosentyx